See also this year's filing and all EDGAR filings for this company.
PDF Report 0001467652_2020_Neos_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001467652')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001467652, Neos Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 66,559,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 12,543,000 |
| 2 | PropertyPlantAndEquipmentNet | 7,345,000 |
| 3 | remainder_Assets | 4,426,000 |
| 4 | LiabilitiesCurrent | 63,355,000 |
| 5 | LiabilitiesNoncurrent | 33,648,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 25,123,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,237,000 |
| 9 | ResearchAndDevelopmentExpense | 8,582,000 |
| 10 | remainder_Expenses | 36,142,000 |
| 11 | remainder_Revenues | 64,649,000 |
| 12 | remainder_NetIncome | 1,533,000 |
| 13 | remainder_ComprehensiveNetIncome | 1,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 90,873,000 |
| 1 | Liabilities | 97,003,000 |
| 2 | Expenses | 83,084,000 |
| 3 | Revenues | 64,649,000 |
| 4 | StockholdersEquity | -6,130,000 |
| 5 | NetIncome | -16,902,000 |
| 6 | ComprehensiveNetIncome | -16,901,500 |
| 7 | BaseVar | 168,571,500 |
| 8 | EconomicCapitalRatio | -0.292 |
Edgar->Model Mapping
Feature Distribution
Change over Time
